ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 474,59
0,69%
Dow Jones
43 136,89
1,45%
DAX
20 574,68
1,55%
Brent Oil
80,685
1,24%
Bitcoin
99 131,02
2,72%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) Actualités

FEMY

Femasys (FEMY)

Femasys Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateHeureSourceTitreSymboleSociété
03/12/202415h00GlobeNewswire Inc.Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeedNASDAQ:FEMYFemasys Inc
26/11/202414h30GlobeNewswire Inc.Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility TreatmentNASDAQ:FEMYFemasys Inc
12/11/202422h01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FEMYFemasys Inc
12/11/202414h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FEMYFemasys Inc
12/11/202414h30GlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
07/11/202414h30GlobeNewswire Inc.Femasys to Exhibit at the Annual AAGL 2024 Global ConferenceNASDAQ:FEMYFemasys Inc
01/11/202413h30GlobeNewswire Inc.Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNASDAQ:FEMYFemasys Inc
30/10/202414h00GlobeNewswire Inc.Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeedNASDAQ:FEMYFemasys Inc
29/10/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
10/10/202414h30GlobeNewswire Inc.Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education ProgramNASDAQ:FEMYFemasys Inc
08/10/202414h30GlobeNewswire Inc.Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitNASDAQ:FEMYFemasys Inc
02/10/202414h30GlobeNewswire Inc.Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsNASDAQ:FEMYFemasys Inc
18/09/202414h30GlobeNewswire Inc.Femasys Announces Infertility Clinic Customers from Coast to CoastNASDAQ:FEMYFemasys Inc
11/09/202414h30GlobeNewswire Inc.Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish MarketNASDAQ:FEMYFemasys Inc
09/09/202414h30GlobeNewswire Inc.Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube CheckNASDAQ:FEMYFemasys Inc
05/09/202414h30GlobeNewswire Inc.Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual MeetingNASDAQ:FEMYFemasys Inc
03/09/202414h30GlobeNewswire Inc.Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FEMYFemasys Inc
29/08/202414h30GlobeNewswire Inc.Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment SolutionNASDAQ:FEMYFemasys Inc
27/08/202414h30GlobeNewswire Inc.Femasys Hosts Congresswoman Lucy McBath at Georgia HeadquartersNASDAQ:FEMYFemasys Inc
08/08/202414h30GlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
15/07/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
27/06/202414h30GlobeNewswire Inc.Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in AmsterdamNASDAQ:FEMYFemasys Inc
20/06/202414h30GlobeNewswire Inc.Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in EuropeNASDAQ:FEMYFemasys Inc
07/06/202422h01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FEMYFemasys Inc
17/05/202414h30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeNASDAQ:FEMYFemasys Inc
16/05/202414h30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy CouncilNASDAQ:FEMYFemasys Inc
09/05/202414h30GlobeNewswire Inc.Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
07/05/202414h30GlobeNewswire Inc.Femasys Expands Commercial Management Team with Addition of Experienced New HiresNASDAQ:FEMYFemasys Inc
18/04/202414h30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
28/03/202421h05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
RI
Pernod Ricard
COIN
XRPUSD
Ripple
EU
EN
Bouygues
EU
ML
Michelin
EU
CAP
Capgemini
NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
COIN
AVAXUSD
Avalanche
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
EU
CS
Axa
EU
VK
Vallourec
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés